Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation
The unique ability of Vδ1+ T cells to recognize targets in a major histocompatibility complex (MHC)-unrestricted manner makes them promising candidates for immunotherapy. This review explores the biological underpinnings of their advantages, particular…